IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 221 filers reported holding IVERIC BIO INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $36,981,600 | +15.2% | 1,520,000 | +1.3% | 5.29% | +40.7% |
| Q4 2022 | $32,115,000 | +19.3% | 1,500,000 | 0.0% | 3.76% | +13.7% |
| Q3 2022 | $26,910,000 | -11.2% | 1,500,000 | -16.7% | 3.31% | -15.8% |
| Q1 2022 | $30,294,000 | +39.4% | 1,800,000 | +38.5% | 3.93% | +75.2% |
| Q4 2021 | $21,736,000 | +37.8% | 1,300,000 | -48.0% | 2.24% | +69.1% |
| Q2 2021 | $15,775,000 | +112.7% | 2,500,000 | +108.3% | 1.33% | +83.1% |
| Q1 2021 | $7,416,000 | +61.6% | 1,200,000 | +33.3% | 0.72% | -21.0% |
| Q2 2020 | $4,590,000 | +2.2% | 900,000 | +71.9% | 0.92% | -17.2% |
| Q4 2019 | $4,491,000 | – | 523,462 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |